← Back to Clinical Trials
Recruiting NCT06249958

NCT06249958 Transforming Rehabilitation: Personalised Care for a Better Quality of Life

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06249958
Status Recruiting
Phase
Sponsor I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Condition Osteoarthritis Secondary
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2024-01-08
Primary Completion 2024-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
RehabilitationVerticalisation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2024-01-08 with a primary completion date of 2024-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

General aim of the project: building and validating an Artificial Intelligence (AI)-based prediction model on rehabilitation outcomes (total joint replacement - TJR - of the hip and knee for primary and secondary osteoarthritis) Purpose of this specific approval request: identifying data from patients admitted for total joint replacement surgery (hip and knee) at Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Ortopedico Galeazzi (IOG) in 2019 and subsequently discharged to inpatient rehabilitation in the same institution.

Eligibility Criteria

Inclusion Criteria: * Patients admitted for inpatient surgery at IRCCS Galeazzi Orthopedic Institute in 2019 (January-December) and subsequently discharged to inpatient rehabilitation in the same structure. * Ages ≥18 years * International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9CM) Diagnoses: 715.15, 16, 25, 26 (primary and secondary osteoarthritis of the hip and knee) * ICD-9CM Surgical procedures: 81.51, 81.54 (total joint replacement of the hip and knee). Exclusion Criteria: N/A

Contact & Investigator

Central Contact

Federico Pennestri, PhD

✉ federico.pennestri@grupposandonato.it

📞 0283502224

Frequently Asked Questions

Who can join the NCT06249958 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Osteoarthritis Secondary. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06249958 currently recruiting?

Yes, NCT06249958 is actively recruiting participants. Contact the research team at federico.pennestri@grupposandonato.it for enrollment information.

Where is the NCT06249958 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT06249958 clinical trial?

NCT06249958 is sponsored by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology